Study validating Turmeric’s effects on Type 2 Diabetes

Posted by Team Curegarden on

One of the natural remedies used since ancient times is turmeric. Turmeric’s medicinal properties come from its most active compound called curcumin. While curcumin is a natural solution for metabolic disorders, its many benefits have been hampered by its poor absorption and availability to inflamed tissues.
Bio-available curcumin (BCM-95™) is produced with a unique and patented process that delivers a superior-absorbing curcumin formulation that is seven times more bio-available than conventional curcumin extracts. According to a study published in the journal “Diabetes Care”, the journal of the American Diabetes Association, revealed that turmeric extract was 100% successful at preventing pre diabetic patients from becoming diabetic. The study was also conducted to check whether curcuminhelps in delaying the development of type 2 diabetes mellitus (T2DM) as well.
A Random,but controlled trial including 240 subjects who met the American Diabetic Association’s criteria for prediabetes was conducted. All subjects were randomly assigned to receive either 250 mg of curcuminoid or placebo capsules for 9 months.
Type 2 diabetes was assessed by measuring a wide range of parameters, including changes in the insulin-producing cells within the pancreas known as β-cells, insulin resistance, and the anti-inflammatory cytokine known as adiponectin, at four different times: baseline, 3-, 6-, and 9-month visits during the course of intervention.


After a period of 9 months, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group . In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group.


A 9-month inclusion of curcumin in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin inclusion in a prediabetic population may be beneficial. Source :

Curegarden’sGluco Balance combines the benefits of turmeric (BCM-95™), amla and pterocarpus to create one powerful solution for blood sugar imbalance.Natural Gluco Balance works as an adjunct therapy.

Natural Gluco Balance: Key benefits

The known benefits of Curegarden Gluco Balance are:

  • Powerful combination of three clinically studied botanicals
  • Turmeric (BCM-95™), amla and pterocarpus target blood sugar balance
  • Impacts healthy blood sugar metabolism in several ways
  • Combats the complications related to blood sugar imbalance
  • Totally safe, with no negative side effects


Share this post

← Older Post Newer Post →

About Curegarden

Curegarden represents a dream. A dream of sharing a happier, healthier body and quality of life with the use of nature's best ingredients. Botanics, when extracted for their bio-active compounds, offer a most effective approach to improving well-being and quality of life. It is based on the belief that botanical of the highest quality would have a positive effect — without any negative side effects — on people's health. Over the years,we have seen and experienced personally the wonderful benefits of these high quality botanical products and are delighted to share them with others.

About Arjuna Naturals

Arjuna Natural Ltd is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for over two decades. With customers in around 40 countries, the company has close to 50 patents to its credit of which majority are commercialized globally. The company has R&D tie ups with international universities from Australia, US and Japan. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.